Pyxis Oncology Announces $50 Million Private Placement

BOSTON, Mass., Feb. 27, 2024 -- Pyxis Oncology, Inc. , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that it has...

Related Keywords

Boston ,Massachusetts ,United States ,Pamela Connealy ,Pyxis Oncology Inc ,Exchange Commission ,Nasdaq ,Deep Track Capital ,Blue Owl Healthcare Opportunities ,Laurion Capital Management ,Lifesci Capital ,Securities Act ,Pyxis Oncology ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,Markets ,